PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
PHASE2
Background:
One way to treat liver cancer is to deliver chemotherapy drugs...
Study of Three Endpoints to Assess the Benefit of Rehabilitation in Patients With Advanced Non-small Cell Lung Cancer Controlled After at Least 6 Months of Systemic Treatment
N/A
The objective of this study is to identify an outcome that is relevant for ...
Status
Not Yet Recruiting
Location
CH Métropole Savoie
Start Date
2026-03
Trial ID
NCT07434947
Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures
N/A
Prospective inclusion of 1000 patients with pancreatic cancer (early-stage ...
Status
Not Yet Recruiting
Location
First Affiliated Hospital, Medical College of Zhejiang University
Start Date
2024-08-01
Trial ID
NCT06495749
Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy
PHASE2
This study is a prospective, open-label, single-arm phase II clinical trial...
Status
Recruiting
Location
First Affiliated Hospital of Nanjing Medical Unviersity
Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments
PHASE3
Comparison of olaparib vs. physician's choice of single agent standard of c...